Hence, future research efforts can be focused on identifying drug targets capable of inhibiting ABCC4 expression, aiming to enhance the efficacy of anti-inflammatory drugs in the treatment of RA. This evidence concerns the gene ABCC4 and rheumatoid arthritis.